PRRC1
gene geneOn this page
Also known as FLJ32875
Summary
PRRC1 (proline rich coiled-coil 1, HGNC:28164) is a protein-coding gene on chromosome 5q23.2, encoding Protein PRRC1 (Q96M27). May act as a regulator of the protein kinase A (PKA) activity during embryonic development.
Predicted to enable protein kinase A regulatory subunit binding activity. Predicted to be involved in epithelial structure maintenance. Predicted to be located in Golgi apparatus. Predicted to be active in cytoplasm.
Source: NCBI Gene 133619 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 96 total
- MANE Select transcript:
NM_130809
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28164 |
| Approved symbol | PRRC1 |
| Name | proline rich coiled-coil 1 |
| Location | 5q23.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ32875 |
| Ensembl gene | ENSG00000164244 |
| Ensembl biotype | protein_coding |
| OMIM | 621301 |
| Entrez | 133619 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 4 protein_coding, 2 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000296666, ENST00000442138, ENST00000507774, ENST00000512635, ENST00000512871, ENST00000513427, ENST00000715263
RefSeq mRNA: 2 — MANE Select: NM_130809
NM_001286808, NM_130809
CCDS: CCDS4143, CCDS68943
Canonical transcript exons
ENST00000296666 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001082709 | 127530294 | 127530396 |
| ENSE00001082712 | 127526618 | 127526778 |
| ENSE00001082713 | 127523460 | 127523582 |
| ENSE00001082714 | 127533623 | 127533786 |
| ENSE00001082715 | 127524531 | 127524920 |
| ENSE00001082716 | 127547819 | 127547921 |
| ENSE00001082717 | 127539040 | 127539143 |
| ENSE00004026362 | 127551707 | 127555085 |
| ENSE00004026363 | 127517640 | 127517776 |
Expression profiles
Bgee: expression breadth ubiquitous, 283 present calls, max score 97.27.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 69.8304 / max 404.7280, expressed in 1822 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 58334 | 52.3734 | 1817 |
| 58335 | 16.3942 | 1804 |
| 58336 | 0.6527 | 367 |
| 203676 | 0.4101 | 204 |
Top tissues by expression
301 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| tibia | UBERON:0000979 | 97.27 | gold quality |
| jejunal mucosa | UBERON:0000399 | 96.23 | gold quality |
| secondary oocyte | CL:0000655 | 95.39 | gold quality |
| stromal cell of endometrium | CL:0002255 | 94.96 | gold quality |
| oocyte | CL:0000023 | 94.84 | gold quality |
| islet of Langerhans | UBERON:0000006 | 94.82 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 94.77 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 94.64 | gold quality |
| skin of hip | UBERON:0001554 | 94.51 | gold quality |
| colonic mucosa | UBERON:0000317 | 94.11 | gold quality |
| mammary duct | UBERON:0001765 | 93.68 | gold quality |
| endometrium | UBERON:0001295 | 93.63 | gold quality |
| eye | UBERON:0000970 | 93.39 | gold quality |
| upper leg skin | UBERON:0004262 | 93.36 | gold quality |
| corpus epididymis | UBERON:0004359 | 93.18 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 92.99 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 92.84 | gold quality |
| placenta | UBERON:0001987 | 92.68 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 92.66 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 92.63 | gold quality |
| nasopharynx | UBERON:0001728 | 92.62 | gold quality |
| cartilage tissue | UBERON:0002418 | 92.62 | gold quality |
| cauda epididymis | UBERON:0004360 | 92.50 | gold quality |
| caput epididymis | UBERON:0004358 | 92.49 | gold quality |
| adrenal tissue | UBERON:0018303 | 92.44 | gold quality |
| oral cavity | UBERON:0000167 | 92.22 | gold quality |
| nipple | UBERON:0002030 | 92.19 | gold quality |
| penis | UBERON:0000989 | 92.14 | gold quality |
| amniotic fluid | UBERON:0000173 | 92.12 | gold quality |
| parietal pleura | UBERON:0002400 | 91.92 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 9.33 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
197 targeting PRRC1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-MIR-518D-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-518E-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-518F-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-519A-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-519B-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-519C-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-520C-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-522-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-523-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-526A-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-5692B | 100.00 | 71.32 | 2622 |
| HSA-MIR-5692C | 100.00 | 71.32 | 2622 |
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-4510 | 100.00 | 66.60 | 2050 |
| HSA-MIR-6127 | 100.00 | 66.76 | 2188 |
| HSA-MIR-6129 | 100.00 | 66.46 | 2080 |
| HSA-MIR-6130 | 100.00 | 66.69 | 2012 |
| HSA-MIR-6133 | 100.00 | 66.48 | 2064 |
| HSA-MIR-4668-3P | 100.00 | 68.74 | 2635 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | prrc1 | ENSDARG00000044304 |
| mus_musculus | Prrc1 | ENSMUSG00000024594 |
| rattus_norvegicus | Prrc1 | ENSRNOG00000016433 |
| caenorhabditis_elegans | WBGENE00015454 |
Protein
Protein identifiers
Protein PRRC1 — Q96M27 (reviewed: Q96M27)
Alternative names: Proline-rich and coiled-coil-containing protein 1
All UniProt accessions (1): Q96M27
UniProt curated annotations — full annotation on UniProt →
Function. May act as a regulator of the protein kinase A (PKA) activity during embryonic development.
Subunit / interactions. Interacts with PRKAR1A; resulting in PKA activation.
Subcellular location. Golgi apparatus. Cytoplasm.
Tissue specificity. Ubiquitously expressed with higher expression in kidney, liver and placenta. Detected in embryonic kidney cells (HEK293 cells) (at protein level). Specifically expressed in liver.
Miscellaneous. Non-canonical splice sites for exon 9 and exon 10.
Similarity. Belongs to the PRRC1 family.
Isoforms (5)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q96M27-1 | 1 | yes |
| Q96M27-2 | 2 | |
| Q96M27-3 | 3 | |
| Q96M27-4 | 4 | |
| Q96M27-5 | 5 |
RefSeq proteins (2): NP_001273737, NP_570721* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR026533 | NTPase/PRRC1 | Domain |
| IPR026534 | PRRC1 | Family |
| IPR029001 | ITPase-like_fam | Homologous_superfamily |
Pfam: PF01931
UniProt features (15 total): splice variant 6, region of interest 2, sequence conflict 2, compositionally biased region 2, modified residue 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96M27-F1 | 68.93 | 0.42 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 209, 408
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 215 (showing top):
RNGTGGGC_UNKNOWN, NKX25_02, MODULE_45, DARWICHE_SKIN_TUMOR_PROMOTER_DN, DARWICHE_PAPILLOMA_RISK_LOW_UP, DARWICHE_PAPILLOMA_RISK_HIGH_UP, DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN, MODULE_16, OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP, MODULE_239, GATA1_03, GOBP_MULTICELLULAR_ORGANISMAL_LEVEL_HOMEOSTASIS, MORI_PLASMA_CELL_UP, GOBP_EPITHELIAL_STRUCTURE_MAINTENANCE, ACEVEDO_LIVER_CANCER_UP
GO Biological Process (1): epithelial structure maintenance (GO:0010669)
GO Molecular Function (3): protein kinase A regulatory subunit binding (GO:0034237), identical protein binding (GO:0042802), protein binding (GO:0005515)
GO Cellular Component (2): cytoplasm (GO:0005737), Golgi apparatus (GO:0005794)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| tissue homeostasis | 1 |
| protein kinase A binding | 1 |
| protein binding | 1 |
| binding | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| cytoplasm | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
658 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PRRC1 | SAR1A | Q9NR31 | 585 |
| PRRC1 | MINAR2 | P59773 | 507 |
| PRRC1 | DNHD1 | Q96M86 | 454 |
| PRRC1 | SPMIP10 | Q6ZNM6 | 418 |
| PRRC1 | DNASE1L1 | P49184 | 392 |
| PRRC1 | NUDT5 | Q9UKK9 | 384 |
| PRRC1 | TEX36 | Q5VZQ5 | 366 |
| PRRC1 | CTXN3 | Q4LDR2 | 360 |
| PRRC1 | MINAR1 | Q9UPX6 | 348 |
| PRRC1 | C5orf63 | A6NC05 | 348 |
| PRRC1 | TTC22 | Q5TAA0 | 338 |
| PRRC1 | TRAPPC2 | P0DI81 | 328 |
| PRRC1 | SEC23A | Q15436 | 325 |
| PRRC1 | TNRC18 | O15417 | 323 |
| PRRC1 | FKBP11 | Q9NYL4 | 321 |
IntAct
52 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PLK1 | SPAG9 | psi-mi:“MI:0914”(association) | 0.790 |
| CFTR | ESYT2 | psi-mi:“MI:2364”(proximity) | 0.710 |
| SEC23A | SEC24D | psi-mi:“MI:0914”(association) | 0.690 |
| HTT | PRRC1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| YWHAG | BLTP3B | psi-mi:“MI:0914”(association) | 0.640 |
| YWHAH | BLTP3B | psi-mi:“MI:0914”(association) | 0.570 |
| PRRC1 | PIN1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PRRC1 | SEC23B | psi-mi:“MI:0915”(physical association) | 0.560 |
| PIN1 | PRRC1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SEC23B | PRRC1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PRRC1 | CDC5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CDC5 | PRRC1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PRRC1 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| AP3D1 | psi-mi:“MI:0914”(association) | 0.460 | |
| TSG101 | PRRC1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| Plk1 | psi-mi:“MI:0915”(physical association) | 0.400 | |
| PRRC1 | psi-mi:“MI:0915”(physical association) | 0.370 | |
| HTT | psi-mi:“MI:0914”(association) | 0.350 | |
| apa | NUDT21 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (74): PRRC1 (Two-hybrid), PRRC1 (Two-hybrid), PRRC1 (Affinity Capture-MS), PRRC1 (Affinity Capture-MS), HNRNPA1 (Co-fractionation), NPEPL1 (Co-fractionation), PAFAH1B2 (Co-fractionation), PPIB (Co-fractionation), PRRC1 (Co-fractionation), PRRC1 (Co-fractionation), PRRC1 (Co-fractionation), PRRC1 (Co-fractionation), PRRC1 (Co-fractionation), PSMG1 (Co-fractionation), RAB1A (Co-fractionation)
ESM2 similar proteins: A0A8M1NHK4, A3KFF6, A6H8J1, O49429, O80678, O80910, P12348, P55265, P94017, P97765, Q08B53, Q13434, Q32SG5, Q3T1I4, Q3TJZ6, Q3UMQ8, Q3UPH1, Q4R3M1, Q5F3N9, Q5FWT1, Q5R679, Q5XJA3, Q5Z8L1, Q66H68, Q6ICG8, Q6P870, Q7G6K7, Q7ZYB4, Q8AVN9, Q8LA32, Q8R478, Q8R4X3, Q93YP4, Q94JZ8, Q969T9, Q96M27, Q9C5P0, Q9C6S1, Q9D529, Q9FF15
Diamond homologs: A6H8J1, Q08B53, Q3T1I4, Q3UPH1, Q5F3I0, Q5XJA3, Q6P870, Q96M27
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
96 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 76 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1579 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 5:127523457:T:G | acceptor_gain | 1.0000 |
| 5:127523458:A:AG | acceptor_gain | 1.0000 |
| 5:127523459:G:GT | acceptor_gain | 1.0000 |
| 5:127523459:GT:G | acceptor_gain | 1.0000 |
| 5:127523556:C:G | donor_gain | 1.0000 |
| 5:127523579:T:TG | donor_gain | 1.0000 |
| 5:127523579:TTAGG:T | donor_loss | 1.0000 |
| 5:127523580:TAGGT:T | donor_loss | 1.0000 |
| 5:127523581:AGG:A | donor_loss | 1.0000 |
| 5:127523582:GGT:G | donor_loss | 1.0000 |
| 5:127523583:GTAC:G | donor_loss | 1.0000 |
| 5:127523584:T:A | donor_loss | 1.0000 |
| 5:127530397:G:GG | donor_gain | 1.0000 |
| 5:127533618:TTTA:T | acceptor_loss | 1.0000 |
| 5:127533619:TTA:T | acceptor_loss | 1.0000 |
| 5:127533620:TA:T | acceptor_loss | 1.0000 |
| 5:127533621:A:AG | acceptor_gain | 1.0000 |
| 5:127533622:G:GA | acceptor_gain | 1.0000 |
| 5:127533622:GA:G | acceptor_gain | 1.0000 |
| 5:127533622:GAA:G | acceptor_gain | 1.0000 |
| 5:127533622:GAAT:G | acceptor_gain | 1.0000 |
| 5:127533783:AAAAG:A | donor_loss | 1.0000 |
| 5:127533784:AAAGT:A | donor_loss | 1.0000 |
| 5:127533785:AA:A | donor_gain | 1.0000 |
| 5:127533786:AGT:A | donor_loss | 1.0000 |
| 5:127533787:G:A | donor_loss | 1.0000 |
| 5:127533787:GTGA:G | donor_gain | 1.0000 |
| 5:127533788:T:G | donor_loss | 1.0000 |
| 5:127533789:G:GT | donor_loss | 1.0000 |
| 5:127533790:AGT:A | donor_loss | 1.0000 |
AlphaMissense
2831 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 5:127526774:T:A | I217N | 0.999 |
| 5:127530361:T:A | I241N | 0.999 |
| 5:127530361:T:C | I241T | 0.999 |
| 5:127530361:T:G | I241S | 0.999 |
| 5:127530370:T:A | L244Q | 0.999 |
| 5:127530370:T:C | L244P | 0.999 |
| 5:127530382:T:C | M248T | 0.999 |
| 5:127533752:C:A | A296D | 0.999 |
| 5:127539053:G:C | R312P | 0.999 |
| 5:127551750:G:A | G391D | 0.999 |
| 5:127551812:T:A | W412R | 0.999 |
| 5:127551812:T:C | W412R | 0.999 |
| 5:127530373:A:G | D245G | 0.998 |
| 5:127530382:T:G | M248R | 0.998 |
| 5:127547820:T:A | W343R | 0.998 |
| 5:127547820:T:C | W343R | 0.998 |
| 5:127551743:T:A | W389R | 0.998 |
| 5:127551743:T:C | W389R | 0.998 |
| 5:127551749:G:C | G391R | 0.998 |
| 5:127526771:T:C | F216S | 0.997 |
| 5:127526774:T:G | I217S | 0.997 |
| 5:127533722:T:A | V286D | 0.997 |
| 5:127533761:C:A | P299Q | 0.997 |
| 5:127533779:G:A | G305E | 0.997 |
| 5:127551708:C:A | A377D | 0.997 |
| 5:127551750:G:T | G391V | 0.997 |
| 5:127551753:T:C | L392P | 0.997 |
| 5:127526774:T:C | I217T | 0.996 |
| 5:127530325:T:A | V229E | 0.996 |
| 5:127530328:T:A | L230H | 0.996 |
dbSNP variants (sampled 300 via entrez): RS1000133638 (5:127538455 T>C), RS1000140870 (5:127544095 A>G), RS1000223811 (5:127525941 G>C,T), RS1000405185 (5:127545077 C>A), RS1000525760 (5:127554639 C>A,T), RS1000559907 (5:127553092 C>A,T), RS1000629142 (5:127520714 A>C,G), RS1000632073 (5:127553483 T>A,C), RS1000691972 (5:127547364 T>A), RS1000768026 (5:127548760 C>T), RS1000794698 (5:127527382 A>G), RS1000819141 (5:127538801 A>C), RS1000903231 (5:127515955 C>T), RS1001140621 (5:127547001 T>C), RS1001145782 (5:127544861 G>A)
Disease associations
OMIM: gene MIM:621301 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST009391_1080 | Metabolite levels | 8.000000e-06 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0010529 | ribose-5-phosphate measurement |
| EFO:0010530 | ribulose-5-phosphate measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
36 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases expression, increases expression, affects cotreatment, increases methylation | 4 |
| Dronabinol | increases expression | 2 |
| Tobacco Smoke Pollution | affects expression, increases expression | 2 |
| Particulate Matter | decreases expression, increases abundance, increases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| bisphenol F | affects cotreatment, decreases expression | 1 |
| dicrotophos | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| sodium arsenite | increases expression | 1 |
| perfluorooctanoic acid | decreases expression | 1 |
| zinc chromate | increases abundance, increases expression | 1 |
| chromium hexavalent ion | increases abundance, increases expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| pentabromodiphenyl ether | increases expression | 1 |
| nutlin 3 | affects cotreatment, increases secretion | 1 |
| abrine | decreases expression | 1 |
| 2,2’,4,4’-tetrabromodiphenyl ether | increases expression | 1 |
| Arsenic Trioxide | increases expression | 1 |
| Fulvestrant | affects cotreatment, increases methylation | 1 |
| Acetaminophen | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Dactinomycin | affects cotreatment, increases secretion | 1 |
| Dexamethasone | decreases expression, affects cotreatment | 1 |
| Enzyme Inhibitors | decreases activity, increases O-linked glycosylation | 1 |
| Indomethacin | affects cotreatment, decreases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Dihydrotestosterone | increases expression | 1 |
| Thiram | increases expression | 1 |
| Tretinoin | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.